T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INN
1276
Summit Hotel Properties
INN
$656M
| $19.6M | ﹤0.01% |
1,929,475
+635,431
| +49% | +$6.14M |
|
|
BNR
1277
Burning Rock Biotech
BNR
$105M
| $19.5M | ﹤0.01% |
72,467
-13,636
| -16% | -$4.15M |
|
1278
Huntington Ingalls Industries
HII
$12.9B
| $19.5M | ﹤0.01% |
94,492
-5,234
| -5% | -$936K |
|
1279
Lamb Weston
LW
$7.3B
| $19.3M | ﹤0.01% |
249,491
-13,204
| -5% | -$1.04M |
|
1280
H.B. Fuller
FUL
$3.24B
| $19.3M | ﹤0.01% |
306,058
+864
| +0.3% | +$49.1K |
|
|
DMYD
1281
DELISTED
dMY Technology Group, Inc. II
DMYD
| $19.1M | ﹤0.01% |
1,301,336
+3,698
| +0.3% | +$65.7K |
|
|
EB
1282
DELISTED
Eventbrite
EB
| $19M | ﹤0.01% |
858,406
+389,493
| +83% | +$7.84M |
|
1283
Arcutis Biotherapeutics
ARQT
$3.3B
| $19M | ﹤0.01% |
656,421
+393,640
| +150% | +$12.3M |
|
1284
BHP
BHP
$222B
| $19M | ﹤0.01% |
306,701
+4,603
| +2% | +$296K |
|
1285
Henry Schein
HSIC
$10.1B
| $19M | ﹤0.01% |
273,996
-21,764
| -7% | -$1.47M |
|
1286
Universal Health Services
UHS
$10.2B
| $18.9M | ﹤0.01% |
141,497
-54,839
| -28% | -$7.27M |
|
1287
BorgWarner
BWA
$14B
| $18.7M | ﹤0.01% |
458,749
-34,041
| -7% | -$1.33M |
|
|
AGCB
1288
DELISTED
Altimeter Growth Corp 2
AGCB
| $18.7M | ﹤0.01% |
+1,802,822
| New | +$21.5M |
|
|
IPG
1289
DELISTED
Interpublic Group of Companies
IPG
| $18.5M | ﹤0.01% |
634,401
-38,206
| -6% | -$1.01M |
|
1290
Sportsman's Warehouse
SPWH
$46M
| $18.5M | ﹤0.01% |
1,071,503
-4,114,906
| -79% | -$71.6M |
|
1291
Prelude Therapeutics
PRLD
$457M
| $18.3M | ﹤0.01% |
422,991
+35,311
| +9% | +$2.34M |
|
1292
Installed Building Products
IBP
$6.46B
| $18.2M | ﹤0.01% |
164,392
+335
| +0.2% | +$38K |
|
1293
Codexis
CDXS
$175M
| $18.1M | ﹤0.01% |
791,032
+82,298
| +12% | +$1.93M |
|
1294
Nkarta
NKTX
$165M
| $18.1M | ﹤0.01% |
549,468
-153,469
| -22% | -$7.33M |
|
1295
Lincoln National
LNC
$8.44B
| $18.1M | ﹤0.01% |
290,172
-18,646
| -6% | -$1.03M |
|
|
CMA
1296
DELISTED
Comerica
CMA
| $18M | ﹤0.01% |
251,357
-19,521
| -7% | -$1.28M |
|
|
DS
1297
DELISTED
Drive Shack Inc.
DS
| $17.8M | ﹤0.01% |
5,540,633
-105,902
| -2% | -$287K |
|
|
VER
1298
DELISTED
VEREIT, Inc.
VER
| $17.8M | ﹤0.01% |
460,439
+219,379
| +91% | +$8.21M |
|
1299
IPG Photonics
IPGP
$3.71B
| $17.7M | ﹤0.01% |
84,031
-5,279
| -6% | -$1.2M |
|
|
LDL
1300
DELISTED
Lydall, Inc.
LDL
| $17.5M | ﹤0.01% |
520,001
-81,979
| -14% | -$2.8M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.